Suffolk, VA

NASH Research Study – Suffolk, VA

Nonalcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in your liver. The more severe form of NAFLD is called nonalcoholic steatohepatitis (NASH). NASH causes the liver to swell and become damaged. The primary objective of this study is to evaluate the superiority of a combination therapy compared with placebo when administered for 48 weeks in patients with non-cirrhotic NASH with liver fibrosis.

Centricity Research is currently enrolling participants in a NASH research study at our Suffolk, Virginia location. Compensation may be available for time and travel for qualified participants.

Qualifications:

• Ages 18 years or more
• NAS greater than or equal to 4 with a score of at least 1 in each component of the NAS (steatosis, lobular inflammation,
  and ballooning) at Visit 2 liver biopsy, or a historical liver biopsy performed within 12 weeks of randomization
• Fibrosis stage of 1 or greater and below 4 on NASH CRN fibrosis staging system at
  Visit 2 liver biopsy, or a historical liver biopsy performed within 12 weeks of randomization

Study Duration: Up to 64 weeks

Compensation: Up to $1,525 for qualified participants

Location: Centricity Research, 1035 Champions Way #600, Suffolk, VA 23435

You can learn more about this study by visiting clinicaltrials.gov and entering the protocol number K-001-201.

To Learn More, Call Us At 706-321-0495

or Click Here and Someone Will Contact You Shortly!

Click Here

Suffolk, VA – Flu Vaccine Research Study

Flu, also known as influenza, is a viral respiratory illness caused by the influenza virus. Flu can cause a range of symptoms, including fever, cough, sore throat, body aches, fatigue, and sometimes vomiting and diarrhea. The flu can be transmitted from person to person through the air, typically through coughing and sneezing, or by touching a surface contaminated with the flu virus and then touching the mouth or nose. While most people recover from the flu without complications, it can lead to serious health complications or even death, particularly in the elderly, young children, and people with underlying medical conditions.

Centricity Research is currently enrolling participants in a flu research study at our Columbus, Ohio location. Compensation may be available for time and travel for qualified participants.

Location: Centricity Research, 1035 Champions Way #600, Suffolk, VA 23435

You can learn more about this study by visiting clinicaltrials.gov and entering the protocol number C4781004.

To Learn More, Call Us At 706-321-0495

or Click Here and Someone Will Contact You Shortly!

Click Here

Suffolk, VA – High Cholesterol Research Study

Hypercholesterolemia (high cholesterol) is a medical condition characterized by high levels of cholesterol in the blood. Cholesterol is a type of fat that the body needs to build cell membranes and produce hormones. However, when there is too much cholesterol in the bloodstream, it can start to accumulate in the walls of the arteries, leading to a condition called atherosclerosis. Atherosclerosis is a build-up of fatty deposits in the arteries, which can restrict blood flow and increase the risk of heart disease and stroke. There are two types of cholesterol: low-density lipoprotein (LDL) and high-density lipoprotein (HDL). LDL is often referred to as “bad” cholesterol, as it contributes to the buildup of plaque in the arteries, whereas HDL is considered “good” cholesterol, as it helps remove excess cholesterol from the bloodstream.

Centricity Research is currently enrolling participants in a high cholesterol study in our Suffolk, VA location. Compensation may be available for time and travel for qualified participants.

Location: Centricity Research, 1035 Champions Way #600, Suffolk, VA 23435

You can learn more about this study by visiting clinicaltrials.gov and entering the protocol number MK-0616-P015.

To Learn More, Call Us At 706-321-0495

or Click Here and Someone Will Contact You Shortly!

Click Here

Suffolk, VA – Post-Acute COVID-19 Research Study

Post-Acute COVID-19, also known as long COVID or long-haul COVID, refers to the persistent and prolonged effects experienced by some individuals following a COVID-19 infection. While the acute phase of the illness typically lasts for a few weeks, post-acute COVID-19 symptoms can persist for months and significantly impact a person’s physical, cognitive, and emotional well-being. Common symptoms include fatigue, shortness of breath, brain fog, muscle weakness, joint pain, and mood disturbances. Additionally, individuals with post-acute COVID-19 may experience challenges in returning to their normal daily activities and may require ongoing medical care and rehabilitation to manage their symptoms effectively.

Centricity Research is currently enrolling participants in a Post-Acute COVID-19 study in our Suffolk, VA location. Compensation may be available for time and travel for qualified participants.

Location: Centricity Research, 1035 Champions Way #600, Suffolk, VA, 23435

You can learn more about this study by visiting clinicaltrials.gov and entering the protocol number 235-201.

To Learn More, Call Us At 706-321-0495

or Click Here and Someone Will Contact You Shortly!

Click Here

Suffolk, VA – Cardiovascular Risk Research Study

Cardiovascular disease is an umbrella term used to describe a set of conditions that involve the narrowing or blocking of blood vessels which restricts the amount of oxygenated blood pumped to and from the heart. Several factors can contribute to cardiovascular disease, including smoking, unhealthy diet, obesity, high blood pressure, physical inactivity, high cholesterol, and genetics. If any of these factors apply to you or someone you know, consider enrolling in a clinical research study exploring an investigational medication designed to potentially help combat cardiovascular disease risk.

Centricity Research is currently enrolling participants in a cardiovascular risk study at our Suffolk, VA location. Compensation may be available for time and travel for qualified participants.

Qualifications:

• Are 40-79 years of age 
• Are at an increased risk for a first major cardiac event (MACE) – heart attack, stroke, etc. 
• Have no history of major ASCVD: acute coronary syndrome, myocardial infarction, ischemic stroke, peripheral artery disease 
• LDL-C ≥70 mg/dL (≥1.81 mmol/L) but <190 mg/dL (<4.91 mmol/L) at the screening visit

Study Duration: Up to 6.3 years

Compensation: May be available for qualified participants

Location: Centricity Research, 1035 Champions Way #600 Suffolk VA 23435

You can learn more about this study by visiting clinicaltrials.gov and entering the protocol number CKJX839D12302.

To Learn More, Call Us At 706-321-0495

or Click Here and Someone Will Contact You Shortly!

Click Here